Compound 3

Methyl (β-D-glucopyranosyluronate)-(1→4)-(2-deoxy-2-sulfonatamido-α-D-glucopyranosyl)-(1→4)-(2-O-sulfonato-α-L-idopyranosyluronate)-(1→4)-(2-acetamido-2-deoxy-α-D-glucopyranosyl)-(1→4)-(2-O-sulfonato-α-L-idopyranosyluronate)-(1→4)-(2-deoxy-2-sulfonatamido-α-D-glucopyranosyl)-(1→4)-(2-O-sulfonato-α-L-idopyranosyluronate)-(1→4)-2-amino-2-deoxy-3,6-di-O-sulfonato-α-D-glucopyranoside undecasodium salt

From: Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host–cell interaction

View in PubChem | MDL Molfile | ChemDraw

InChIKey LQHPINRGPQMINY-YALHFCBISA-C

Synthetic procedure: See article for the definitive version of this procedure and for full experimental details.

A mixture of the compound 55 (23.7 mg, 7.40 μmol), 0.1 M NaOH(aq) (0.488 mL, 48.8 μmol), triethylamine (0.488 mL, 3.50 mmol), and sulfur trioxide-pyridine complex (46.4 mg, 0.296 mmol) in methanol (0.6 mL) were kept stirring at room temperature for 18 h. After the starting material was completely consumed, the solvent was evaporated under reduced pressure, and the residue was finally purified by column chromatography on Sephadex LH-20 using methanol as an eluent to yield the N-sulfonated compound. A solution of the N-sulfonated compound and 20% Pd(OH)2 on carbon (0.221 mg) in phosphate buffer (20 mM, pH = 7.0, 3 mL) was equipped with a hydrogen balloon, and the mixture was stirred at room temperature for 2 d. The whole mixture was filtered through celite, and the filtrate was concentrated in vacuo. The residue was dissolved in water (1 mL), the residue was purified through a Sephadex G-25 column eluted with water. After concentration, the residue was passed through a column of Biorad 50 X 8 Na+ resin using water as eluent. The product fraction was lyophilized to give the target molecule 3 (7.73 mg, 47% overall yield in two steps). 1H NMR (600 MHz, D2O) δ 5.58 (d, J = 3.4 Hz, 1H, H-1''), 5.36 (d, J = 3.4 Hz, 1H, H-1''''''), 5.27 (s, 1H, H-1'''''), 5.22 (s, 1H, H-1'''), 5.17 (d, J = 4.6 Hz, 1H, H-1'), 5.13 (d, J = 3.6 Hz, 1H, H-1''''), 5.11-5.10 (m, 2H, H-5', H-5'''), 5.07 (d, J = 3.5 Hz, 1H, H-1), 4.96 (s, 1H, H-5'''''), 4.68 (t, J = 9.6 Hz, 1H, H-3), 4.56 (d, J = 7.9 Hz, 1H, H-1'''''''), 4.50 (dd, J = 11.6, 3.4 Hz, 1H, H-6a), 4.39 (d, J = 11.6, 1H, H-6b), 4.36-4.34 (m, 3H, H-2', H-2''', H-2'''''), 4.29 (s, 2H, H-3''', H-3'''''), 4.26 (t, J = 3.8 Hz, 1H, H-4'), 4.15 (dd, J = 8.9, 3.8 Hz, 1H, H-3'), 4.13-4.12 (m, 1H, H-5), 4.08-4.02 (m, 4H, H-4, H-4''', H-4''''', H-2''''), 3.94-3.86 (m, 8H, H-5'', H4'''', H-6''×2, H-6''''×2, H-6''''''×2), 3.85-3.81 (m, 3H, H-4'''''', H-4''''''', H-5''''), 3.78-3.73 (m, 4H, H-3'''', H-3'''''', H-4'', H-5''''''), 3.70 (dd, J = 10.7, 3.5 Hz, 1H, H-2), 3.63 (t, J = 9.8 Hz, 1H, H-3''), 3.58-3.54 (m, 2H, H-3''''''', H-5'''''''), 3.49 (s, 3H, CH3), 3.41 (td, J = 7.9, 3.5 Hz, 1H, H-2'''''''), 3.30-3.26 (m, 2H, H-2'', H-2''''''), 2.09 (s, 3H, CH3); 13C NMR (150 MHz, D2O) δ 175.3 (C), 174.8 (C×2), 172.1 (C), 101.9 (CH), 99.2 (CH×2), 99.1 (CH), 97.3 (CH), 95.7 (CH), 95.3 (CH), 93.7 (CH), 77.7 (CH), 77.5 (CH), 77.4 (CH), 76.9 (CH), 75.7 (CH×2), 75.67 (CH), 75.6 (CH), 75.0 (CH×2), 74.6 (CH), 74.5 (CH), 73.2 (CH), 72.7 (CH), 71.7 (CH), 71.4 (CH×2), 71.35 (CH), 70.9 (CH), 70.7 (CH), 70.6 (CH), 69.8 (CH), 69.5 (CH), 69.3 (CH), 69.1 (CH), 67.8 (CH), 67.6 (CH), 65.8 (CH2), 63.5 (CH), 59.7 (CH2), 59.5 (CH2), 59.3 (CH2), 58.1 (CH), 57.7 (CH), 55.3 (CH3), 53.5 (CH), 53.3 (CH), 22.2 (CH3); HR-ESI-MS (m/z): [M-9H+6Na]3- calcd. for C51H73N4O63Na6S7, 703.6688; found, 703.6695; [M-8H+5Na]3- calcd. for C51H74N4O63Na5S7, 696.3414; found, 696.3416; [M-7H+4Na]3- calcd. for C51H75N4O63Na4S7, 689.0141; found, 689.0150; [M-6H+3Na]3- calcd. for C51H76N4O63Na3S7, 681.6868; found, 681.6859; [M-5H+2Na]3- calcd. for C51H77N4O63Na2S7, 674.3595; found, 674.3558; [M-4H+Na]3- calcd. for C51H78N4O63NaS7, 667.0321; found, 667.0350.